Hyderabad: 05th April, 2024 - Hyderabad, India - April 4, 2024 - 9M Fertility, a pioneering division of Ankura Hospital for Women and Children, proudly celebrates its first anniversary with groundbreaking achievements in the field of assisted reproduction.
Ankura Hospital, renowned for its commitment to delivering high-quality healthcare services, introduced 9M Fertility as a beacon of excellence in infertility care. Over the past year, 9M Fertility has emerged as a leader in the industry, boasting an exceptional overall success rate of 79.5%.
In recent months, 9M Fertility has achieved remarkable success rates, with a soaring 82% success rate in the last three months and a consistent 83% success rate over the last six months. These figures far surpass global averages for fertility treatments, setting a new standard for excellence in reproductive medicine.
The success of 9M Fertility is attributed to its commitment to four pillars: Ethical and transparent service, Individualized approach, Evidence-based treatments, and Advanced technology. By leveraging advanced fertility treatment options such as Pre-genetic tests (PGT) and the Endometrial receptive array (ERA), 9M Fertility ensures higher chances of success and healthy outcomes for couples undergoing infertility treatments. Pre-genetic tests (PGT), such as PGT-A, PGT-SR, and PGT-M, test the embryos for genetic abnormality before transplantation to the uterus. Genetic conditions in family, age, and other causes may predispose some couples to having babies with chromosomal abnormalities, such as Down’s syndrome. PGT tests not only assure higher chances of success for infertility treatments but also ensure healthy embryos. The Endometrial receptive array is yet another such test to achieve a higher success rate of fertility treatments. In ERA the uterus lining of the mother-to-be is first examined microscopically to ensure that it is prepared well to receive the embryo, thereby increasing chances of successful implantation. A long list of advanced infertility treatments such as In-vitro fertilization (IVF), In-vitro Maturation (IVM), and Fertility preservation options for couples/individuals who want to delay pregnancy is provided by 9M. What is miraculous is that men who had azoospermia, and were not able to ejaculate sperms effectively due to some underlying problem, have been able to conceive with their own gametes at 9M Fertility. In usual cases, donor sperms are used in such scenarios, but by the availability of advanced tests such as TESA, M TESE at 9M Fertility sperms can be retrieved from fathers-to-be, adding much to the joy of couples.
Dr. Sreevani Kotha, Director and Head of 9M Fertility, emphasizes the importance of personalized care and guidance provided to each couple throughout their infertility journey. "Each case of infertility is unique," says Dr Kotha, "and our expert team at 9M Fertility is dedicated to helping couples understand and tackle infertility with the best available options tailored to their needs."
As infertility rates continue to rise in India and globally, 9M Fertility is poised for expansion to meet the growing demand for specialized infertility care. Dr Durga Prasad, Senior Paediatrician and Cluster Medical Director at Ankura Hospital announces plans for new 9M Fertility centres in Bhubaneswar, Nashik, Vijayawada, Khammam, Tirupati, and additional locations in Hyderabad and Pune and thereby will take the tally up to 11 centres from just 2 centres presently- one each in Hyderabad and Pune.
"Ankura Hospital is trusted by thousands of families for women and child healthcare," says Dr Prasad, "and we are excited to extend our trusted and predictable solutions for infertility through 9M Fertility to more communities."
With its unwavering commitment to buildin